Ameritas Advisory Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Ameritas Advisory Services's DGX Position: Q2 2026 in Review
Ameritas Advisory Services opened a new position in Quest Diagnostics (DGX) in Q2 2026: 211 shares worth $44.6K. The stake represents ﹤0.01% of the portfolio and ranks #1267 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in DGX as recently as Q3 2025.
Ameritas Advisory Services first reported a position in DGX in Q1 2023 and has held it in 4 quarters since. The position peaked at $71.3K in Q1 2023. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Ameritas Advisory Services held 211 shares of Quest Diagnostics worth $44.6K as of Q2 2026.
- Quest Diagnostics was a new Ameritas Advisory Services position in Q2 2026.
- Quest Diagnostics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1267 holding.
- Ameritas Advisory Services first reported a position in Quest Diagnostics in Q1 2023 and has held it in 4 quarters since.
- Ameritas Advisory Services's Quest Diagnostics position peaked at $71.3K in Q1 2023.
- 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.